Neuropace, Inc. NPCE Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$21.47M+20.9% | -$27.14M+17.6% | -$32.96M+30.0% | -$47.08M-30.5% | ||
| $329K+12.3% | $293K+1.7% | $288K-13.8% | $334K-5.4% | ||
| $11.09M+7.8% | $10.28M+7.6% | $9.56M+14.5% | $8.35M+94.7% | ||
| $237K+3.9% | $228K-19.4% | $283K+9.7% | $258K-3.4% | ||
| —— | $0— | —— | -$356K— | ||
| —— | $536K-88.9% | $4.85M— | —— | ||
| —— | $2.43M— | —— | $2.13M+84.5% | ||
| -$730K— | —— | $240K— | —— | ||
| $3.55M— | —— | $3.77M— | —— | ||
| —— | —— | —— | —— | ||
| -$414K+22.5% | -$534K-149% | $1.09M— | $0+100% | ||
| $1.71M+9.5% | $1.56M+9.0% | $1.43M-47.3% | $2.72M— | ||
| -$1.86M-14.3% | -$1.63M-15.0% | -$1.42M+32.7% | -$2.1M— | ||
| -$11.51M+35.9% | -$17.95M+8.9% | -$19.7M+46.6% | -$36.87M-50.0% | ||
| $332K+8.5% | $306K+76.9% | $173K-71.3% | $603K+57.0% | ||
| -$332K-104% | $8.99M-60.9% | $23.03M-3.2% | $23.8M+128% | ||
| —— | $0— | —— | —— | ||
| $1.88M-2.9% | $1.93M+140% | $803K-10.4% | $896K-2.5% | ||
| $543K-38.4% | $881K+240% | $259K+339% | $59K— | ||
| —— | $4.33M-46.8% | $8.13M— | —— | ||
| —— | —— | $11.45M+185% | -$13.5M-81.3% | ||
| $6.2M-0.5% | $6.23M+39.1% | $4.48M+0.3% | $4.46M-29.6% | ||
| $237K+3.9% | $228K-19.4% | $283K+9.7% | $258K-3.4% | ||
| $329K+12.3% | $293K+1.7% | $288K-13.8% | $334K-5.4% | ||
| —— | —— | —— | -$356K— | ||
| $538K-43.6% | $954K-11.3% | $1.08M+23.0% | $874K+8.4% | ||
| -$1.86M-14.3% | -$1.63M-15.0% | -$1.42M+32.7% | -$2.1M— | ||
| —— | —— | —— | —— | ||
| $159K-36.7% | $251K+28.1% | $196K-19.3% | $243K+0.4% | ||
| $1.71M+9.5% | $1.56M+9.0% | $1.43M-47.3% | $2.72M— | ||
| —— | $3.28M-58.5% | $7.89M— | —— | ||
| $1.88M-2.9% | $1.93M+140% | $803K-10.4% | $896K— | ||
| —— | $19K-72.5% | $69K— | —— | ||
| —— | $110K— | —— | $0— | ||
| —— | —— | —— | —— | ||
| -$414K+22.5% | -$534K-149% | $1.09M— | $0— | ||
| -$1.86M-14.3% | -$1.63M-15.0% | -$1.42M+32.7% | -$2.1M— | ||
| -$11.75M+35.7% | -$18.26M+8.1% | -$19.87M+47.0% | -$37.47M-50.1% | ||
| -$11.75M+35.7% | -$18.26M+8.1% | -$19.87M+47.0% | -$37.47M-50.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neuropace, Inc. generate?
- Neuropace, Inc. (NPCE) generated -$9.9M in operating cash flow over the trailing twelve months.
- What is Neuropace, Inc.'s free cash flow?
- After $412.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$10.2M over the trailing twelve months, up 43.5% year over year.
- Where does Neuropace, Inc.'s cash flow data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
